Certara (NASDAQ:CERT) Trading Down 2% - Time to Sell?

Shares of Certara, Inc. (NASDAQ:CERT - Get Free Report) fell 2% during mid-day trading on Tuesday . The stock traded as low as $14.14 and last traded at $14.18. 375,986 shares traded hands during trading, a decline of 68% from the average session volume of 1,189,954 shares. The stock had previously closed at $14.47.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CERT shares. KeyCorp lifted their price target on Certara from $15.00 to $18.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Barclays cut their price target on shares of Certara from $13.00 to $11.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Robert W. Baird lifted their target price on shares of Certara from $9.00 to $13.00 and gave the company a "neutral" rating in a research report on Friday, April 11th. TD Cowen started coverage on Certara in a report on Thursday, February 27th. They issued a "buy" rating and a $16.00 price objective on the stock. Finally, William Blair reissued a "market perform" rating on shares of Certara in a report on Thursday, February 27th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $15.17.

Certara Stock Down 0.5 %

The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86. The business has a 50 day simple moving average of $11.64 and a 200-day simple moving average of $11.49. The firm has a market capitalization of $2.33 billion, a price-to-earnings ratio of -72.00, a P/E/G ratio of 9.29 and a beta of 1.64.

Institutional Trading of Certara

Several hedge funds have recently made changes to their positions in CERT. Versant Capital Management Inc grew its position in Certara by 218.8% in the first quarter. Versant Capital Management Inc now owns 2,719 shares of the company's stock worth $27,000 after acquiring an additional 1,866 shares during the period. Venturi Wealth Management LLC raised its holdings in Certara by 839.1% in the 4th quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company's stock valued at $30,000 after buying an additional 2,509 shares during the period. Wells Fargo & Company MN boosted its stake in Certara by 48.4% during the fourth quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock worth $34,000 after buying an additional 1,047 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Certara during the fourth quarter valued at about $47,000. Finally, Blue Trust Inc. lifted its holdings in shares of Certara by 20.9% in the 4th quarter. Blue Trust Inc. now owns 4,747 shares of the company's stock worth $56,000 after acquiring an additional 822 shares during the last quarter. Hedge funds and other institutional investors own 73.96% of the company's stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.